Structural determinants of vascular endothelial growth factor-D receptor binding and specificity
- PMID: 21148085
- DOI: 10.1182/blood-2010-08-301549
Structural determinants of vascular endothelial growth factor-D receptor binding and specificity
Abstract
Vascular endothelial growth factors (VEGFs) and their tyrosine kinase receptors (VEGFR-1-3) are central mediators of angiogenesis and lymphangiogenesis. VEGFR-3 ligands VEGF-C and VEGF-D are produced as precursor proteins with long N- and C-terminal propeptides and show enhanced VEGFR-2 and VEGFR-3 binding on proteolytic removal of the propeptides. Two different proteolytic cleavage sites have been reported in the VEGF-D N-terminus. We report here the crystal structure of the human VEGF-D Cys117Ala mutant at 2.9 Å resolution. Comparison of the VEGF-D and VEGF-C structures shows similar extended N-terminal helices, conserved overall folds, and VEGFR-2 interacting residues. Consistent with this, the affinity and the thermodynamic parameters for VEGFR-2 binding are very similar. In comparison with VEGF-C structures, however, the VEGF-D N-terminal helix was extended by 2 more turns because of a better resolution. Both receptor binding and functional assays of N-terminally truncated VEGF-D polypeptides indicated that the residues between the reported proteolytic cleavage sites are important for VEGF-D binding and activation of VEGFR-3, but not of VEGFR-2. Thus, we define here a VEGFR-2-specific form of VEGF-D that is angiogenic but not lymphangiogenic. These results provide important new insights into VEGF-D structure and function.
Similar articles
-
Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.J Biol Chem. 2016 Dec 30;291(53):27265-27278. doi: 10.1074/jbc.M116.736801. Epub 2016 Nov 16. J Biol Chem. 2016. PMID: 27852824 Free PMC article.
-
Structural determinants of growth factor binding and specificity by VEGF receptor 2.Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2425-30. doi: 10.1073/pnas.0914318107. Proc Natl Acad Sci U S A. 2010. PMID: 20145116 Free PMC article.
-
The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.Cancer Res. 2008 Jun 15;68(12):4754-62. doi: 10.1158/0008-5472.CAN-07-5809. Cancer Res. 2008. PMID: 18559522
-
Molecular control of lymphatic metastasis.Ann N Y Acad Sci. 2008;1131:225-34. doi: 10.1196/annals.1413.020. Ann N Y Acad Sci. 2008. PMID: 18519975 Review.
-
VEGFR signaling during lymphatic vascular development: From progenitor cells to functional vessels.Dev Dyn. 2015 Mar;244(3):323-31. doi: 10.1002/dvdy.24227. Epub 2014 Dec 4. Dev Dyn. 2015. PMID: 25399804 Review.
Cited by
-
VEGFR-2 conformational switch in response to ligand binding.Elife. 2016 Apr 7;5:e13876. doi: 10.7554/eLife.13876. Elife. 2016. PMID: 27052508 Free PMC article.
-
Beyond vessels: unraveling the impact of VEGFs on neuronal functions and structure.J Biomed Sci. 2025 Mar 6;32(1):33. doi: 10.1186/s12929-025-01128-8. J Biomed Sci. 2025. PMID: 40050849 Free PMC article. Review.
-
Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives.Signal Transduct Target Ther. 2025 May 19;10(1):170. doi: 10.1038/s41392-025-02249-0. Signal Transduct Target Ther. 2025. PMID: 40383803 Free PMC article. Review.
-
Novel COL4A1-VEGFD gene fusion in myofibroma.J Cell Mol Med. 2021 May;25(9):4387-4394. doi: 10.1111/jcmm.16502. Epub 2021 Apr 8. J Cell Mol Med. 2021. PMID: 33830670 Free PMC article.
-
The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology.J Biol Chem. 2013 Mar 22;288(12):8176-8186. doi: 10.1074/jbc.M112.439299. Epub 2013 Feb 12. J Biol Chem. 2013. PMID: 23404505 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous